Yesterday, we reported that Sunil Kumar Manna, the head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, had retracted two papers for image problems.
Turns out Manna will be retracting eight more, he told us today. Here they are: Continue reading Scientist whose work is “not fully supported by the available laboratory records” to retract 8 more papers
A group of Belgian researchers has retracted two decade-old papers in Arthritis & Rheumatism following an investigation and court case.
The papers involved the use of the drug infliximab — sold by Johnson & Johnson as Remicade — to treat Sjögren’s syndrome, an auto-immune condition marked by the destruction of exocrine glands that secrete saliva and tears.
Infliximab is not approved for Sjögren’s. Although the two now-retracted studies suggested that it might be helpful, subsequent data did not support those findings.
Neither, apparently, did the studies themselves. Here’s the retraction notice (it’s a PDF): Continue reading Authors retract two papers on Remicade following legal battles
Noriyuki Takai, a gynecologic cancer researcher at Oita University in Japan who retracted three papers last October, has four more retractions, these in Cancer Letters.
All but one of the notices reads as follows: Continue reading Retraction count for gynecologic cancer researcher Takai grows to seven
The head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, Sunil Kumar Manna, has retracted two papers for image problems.
Here’s the notice from Cell Death and Differentiation for “Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells:” Continue reading Two retractions for scientist whose work is “not fully supported by the available laboratory records”
Let’s say you’re a researcher who’s just gotten reviews back from your latest manuscript, asking for some revisions. Luckily, you find yourself at a conference and spot a presentation that’s related to your work. So you use a bunch of that presentation material in your paper.
Unfortunately for you, the guy who gave that conference presentation sees your paper when it’s published — and he’s justifiably unhappy enough to contact the editors. Continue reading Need more material for your paper under review? Just take it from someone else’s conference presentation
A Saudi engineer has lost his 2012 paper in Renewable and Sustainable Energy Reviews for plagiarizing from two previously published articles, including one in the same journal.
The article, titled “Fresh water production from/by atmospheric air for arid regions, using solar energy: Review,” was written by A.M.K. El-Ghonemy, of Al-Jouf University.
According to the retraction notice:
Continue reading Fresh water paper proves recycled, gets retracted
Sanjeeb K. Sahoo, of the Institute of Life Sciences in Bhubaneswar, India, has had four papers retracted from Acta Biomaterialia for what the journal is calling “highly unethical practices.”
All four notices say the same thing: Continue reading “Highly unethical practices” force four retractions for nanotech researcher
Retraction Watch readers may recall the case of William Hamman, the United Airlines pilot who claimed to be a cardiologist until the Associated Press uncovered him in late 2010. Hamman had published at least six papers, and since the revelations has had one retraction and one erratum, by our count.
Now comes another retraction, in the Journal of Patient Safety. Here’s the (paywalled) notice, signed by journal editor Charles Denham: Continue reading Paper by fake cardiologist retracted
Rui Curi, the Brazilian scientist whose lawyers’ threats helped force the shutdown of Science-Fraud.org, has corrected another paper criticized by the site.
Here’s the correction for “Effects of moderate electrical stimulation on reactive species production by primary rat skeletal muscle cells: Cross-talk between superoxide and nitric oxide production,” in the Journal of Cellular Physiology: Continue reading Author whose lawyers threatened Science Fraud corrects another paper
A University of Minnesota social scientist who studies health disparities has retracted a study that apparently lacked ethical approval.
Here’s the notice for “Deservingness to state health services for South – South migrants: A preliminary study of Costa Rican providers’ views,” a paper in Social Science & Medicine by Kate Goldade and a colleague: Continue reading Social sciences paper retracted for lack of ethical approval